Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer
Clinical trial NCT05442749 · TERMINATED
Trial details
- NCT number
- NCT05442749
- Sponsor
- Centre Leon Berard
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-28
- Primary completion
- 2024-08-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.